Viatris Handed Another Chance On US Epoprostenol Challenge
US Federal Circuit Orders Viatris Veletri Case Back To District Court
The US Court of Appeals for the Federal Circuit did not agree with the way a lower court adopted critical claim construction language in Viatris’ patent-litigation proceedings with Actelion over its Veletri injectable treatment for pulmonary arterial hypertension.
